pillbase.ru

Skytrofa (previously Lonapegsomatropin Ascendis Pharma)

Active substance: lonapegsomatropin

Lonapegsomatropin

Centralised EU authorisationActive

Marketing holder: Ascendis Pharma Endocrinology Division A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 14
  • Skytrofa
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LONAPEGSOMATROPIN 1.4 mg/1
    73362-013
    Ascendis Pharma Endocrinology, Inc.
  • Skytrofa
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LONAPEGSOMATROPIN 2.5 mg/1
    73362-016
    Ascendis Pharma Endocrinology, Inc.
  • Skytrofa
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LONAPEGSOMATROPIN 4.3 mg/1
    73362-005
    Ascendis Pharma Endocrinology, Inc.
  • Skytrofa
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LONAPEGSOMATROPIN 3 mg/1
    73362-003
    Ascendis Pharma Endocrinology, Inc.
  • Skytrofa
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LONAPEGSOMATROPIN 7.6 mg/1
    73362-008
    Ascendis Pharma Endocrinology, Inc.
All products in this country (14)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-d080-79c3-8a8f-e604ba7d628b,01a1208d-bfc8-728d-b89c-6970fd819fc6,01a12090-f05f-7479-b719-d4b99f039f94,01a12092-ba4a-7b72-b60d-57f9f7ac3903,01a12092-ba4f-7335-a4b4-7d523d7f9fa4;count=14 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005367
Registration status
Active
ATC code
H01AC09
Sources
  • product · EMA · EMEA/H/C/005367 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005367 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005367 · Verified 2026-10-09